Overview
- 34 inspections across 34 sites are on record.
- 153 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-02-09.
At a glance
Inspections
34
Sites
34
Observations
153
Career since
Mar 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Baxter Healthcare Corporation | 9 Feb 2024 | Human Drugs | View 483 → |
| NerPharMa S.r.l. | 20 Feb 2023 | Human Drugs | On file |
| Industrias Farmaceuticas Almirall SA | 3 Feb 2023 | Human Drugs | On file |
| Merz Pharma GmbH & Co KGaA | 22 Nov 2019 | Human Drugs | View 483 → |
| Liof Pharma S.L. | 12 Nov 2019 | Human Drugs | On file |
Sites inspected
Baxter Healthcare CorporationMarion, United States1 insp.
NerPharMa S.r.l.Nerviano, Italy1 insp.
Industrias Farmaceuticas Almirall SASant Andreu De La Barca, Spain1 insp.
Merz Pharma GmbH & Co KGaADessau-Rosslau, Germany1 insp.
Liof Pharma S.L.Vitoria, Spain1 insp.
Co-investigators
Investigators who share inspections with this person.
Dell S Moller4 shared
Adam R Cooke3 shared
Jose A Cruz Gonzalez3 shared
Cynthia Jim2 shared
Yumi J Hiramine2 shared
Margaret M Annes2 shared
Shawn E Larson2 shared
Sandra A Hughes2 shared
Sarah M Forney2 shared
Bruce H Mccullough2 shared
Full investigator report
Get the verbatim findings behind Susan T Hadman's 153 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site